HFX AdaptivAI, a responsive, personalized pain management platform, powers the HFX iQ spinal cord stimulation (SCS) system. The Redwood City, California-based company kicked off a limited market release of the offering following this approval.  It originally launched the HFX iQ system in March 2023.

The company plans for a full market release in the U.S. in the fourth quarter of 2024.

Nevro says its HFX AdaptivAI is the only technology with AI for providing patients suffering from chronic pain with “an unprecedented level of personalized, responsive pain relief.”